Skip to main content
. 2022 Jan 4;23(3):579–599. doi: 10.1007/s11154-021-09705-6

Fig. 1.

Fig. 1

Proposed pathogenic mechanisms leading to severe COVID-19 outcomes in individuals with vitamin D deficiency or insufficiency. ACE2, angiotensin-converting enzyme 2; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. References for evidence: cytokine production [41]; immune modulation [18, 29]; inflammation [53]; blood glucose concentration [149]; renin and angiotensin II levels [64]; and thromboembolic risk [104]